(Total Views: 106)
Posted On: 08/02/2021 10:25:49 AM
Post# of 107225
$GLMD News Article - FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study https://marketwirenews.com/news-releases/fda-...66118.html
(0)
(0)
My Twitter: WhyteStocks
